0HS8:LSE:LSE-Caladrius Biosciences Inc. (USD)

COMMON STOCK | |

Last Closing

USD 2.0653

Change

0.00 (0.00)%

Market Cap

N/A

Volume

66.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-13 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
0R2F:LSE Wells Fargo & Company

+2.45 (+4.04%)

USD 9,223,372,036.85B
0R2T:LSE Micron Technology Inc

+5.10 (+7.60%)

USD 9,223,372,036.85B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0M69:LSE OTP Bank Nyrt

N/A

USD 5,014.80B
0R28:LSE Newmont Corp.

+0.50 (+0.92%)

USD 4,231.43B
0R2O:LSE Freeport-McMoRan Inc.

+1.73 (+5.30%)

USD 4,154.37B
0QYD:LSE Yum! Brands Inc.

+2.96 (+2.07%)

USD 4,109.92B
0Y4Q:LSE Willis Towers Watson PLC

N/A

USD 4,090.61B
0LD9:LSE Targa Resources Corp.

+4.76 (+2.93%)

USD 4,072.69B

ETFs Containing 0HS8:LSE

HAU-U:CA 3.45 % 0.00 %

N/A

N/A
PEJ Invesco Dynamic Leisure a.. 3.28 % 0.63 %

+0.25 (+3.31%)

N/A
SDOG ALPS Sector Dividend Dogs.. 2.28 % 0.40 %

+0.84 (+3.31%)

USD 1.21B
RCD Ready Capital Corporation.. 2.16 % 0.40 %

-0.05 (3.31%)

N/A
IUSF:LSE iShares IV Public Limited.. 0.41 % 0.00 %

+21.63 (+3.31%)

USD 0.31B
IUSZ:LSE iShares Edge MSCI USA Siz.. 0.41 % 0.00 %

+0.36 (+3.31%)

USD 0.31B
BFOR Barron's 400 ETF 0.28 % 0.65 %

+0.68 (+3.31%)

USD 0.14B
FXM:CA First Asset Morningstar C.. 0.00 % 0.67 %

+0.31 (+3.31%)

CAD 0.30B
HOG:CA 0.00 % 0.64 %

N/A

N/A
RXI iShares Global Consumer D.. 0.00 % 0.46 %

+1.16 (+3.31%)

N/A
XDEW:LSE Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

+3.12 (+3.31%)

N/A
XDWE:LSE Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+179.00 (+3.31%)

N/A
XDEW:XETRA Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

+2.53 (+3.31%)

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -27.51% N/A N/A 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.51% N/A N/A 10% F
Trailing 12 Months  
Capital Gain -28.54% N/A N/A 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -28.54% N/A N/A 15% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 106.54% N/A N/A 95% A
Dividend Return 106.54% N/A N/A 95% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 203.61% N/A N/A 9% A-
Risk Adjusted Return 52.33% N/A N/A 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike